Kura Scores A Big Win As FDA Approves Its New Leukemia Pill

benzinga.com/news/fda/25/11/48873174/kura-scores-a-big-win-as-fda-approves-its-new-leukemia-pill

On Thursday, the U.S. Food and Drug Administration granted full approval to Komzifti (ziftomenib), developed by Kura Oncology Inc. (NASDAQ:KURA) and Kyowa Kirin Co., Ltd., for treating relapsed or refractory (R/R) acute myeloid leukemia (AML) with a susceptible NPM1 mutation.
Komzifti is…

This story appeared on benzinga.com, 2025-11-14 17:43:58.
The Entire Business World on a Single Page. Free to Use →